Advanced Selective Estrogen Receptor Modulator (SERM)
Dragon Pharma Enclomiphene 25 mg tablets represent the next generation of Selective Estrogen Receptor Modulators (SERMs) specifically engineered for bodybuilders and athletes seeking optimized Post Cycle Therapy (PCT) and testosterone restoration. As the trans-isomer of Clomiphene, Enclomiphene offers targeted estrogen receptor modulation without the estrogenic activity associated with zuclomiphene, making it a superior choice for hormonal recovery and testosterone optimization protocols.
Manufactured in certified European facilities under strict pharmaceutical standards, each tablet delivers precisely 25 mg of pure Enclomiphene, packaged in convenient sachets of 100 tablets. This advanced formulation selectively stimulates gonadotropin secretion by blocking estrogen receptors in the hypothalamus, resulting in increased production of Luteinizing Hormone (LH) and Follicle Stimulating Hormone (FSH). For bodybuilders in the USA coming off anabolic cycles or seeking natural testosterone enhancement, Dragon Pharma Enclomiphene provides a scientifically advanced approach to hormonal management.
Unlike traditional Clomid which contains both enclomiphene and zuclomiphene isomers, Dragon Pharma's pure Enclomiphene formulation eliminates the estrogenic zuclomiphene component. This results in more predictable testosterone stimulation with fewer side effects such as mood swings, vision disturbances, and estrogenic activity that some users experience with conventional Clomid. The 25 mg strength offers optimal dosing flexibility for various protocols, from aggressive PCT following heavy cycles with compounds like Trenbolone to milder testosterone optimization regimens.
For athletes and bodybuilders, Enclomiphene serves multiple critical functions: it effectively restores natural testosterone production after suppression from anabolic compounds, helps preserve hard-earned muscle mass during PCT, supports sexual function and libido during hormonal transitions, and can even be used as part of a testosterone optimization protocol for those seeking to enhance natural androgen levels without exogenous testosterone. When stacked strategically with other ancillaries like Aromasin for estrogen control, it creates a comprehensive hormonal recovery environment.
Quality verification is paramount with Dragon Pharma products. This Enclomiphene batch underwent independent third-party laboratory testing on October 16, 2025, confirming a content of 25.19 mg per tablet—an exceptional 100.76% accuracy to the claimed 25 mg dosage. This lab verification ensures users receive precisely what's labeled, providing confidence in dosing consistency for critical hormonal recovery protocols.
Key Benefits:
Each sachet contains 100 tablets of 25mg Enclomiphene, manufactured under strict quality control standards in Dragon Pharma's certified facilities and independently verified for potency and purity through third-party laboratory testing.
| Product Name | Enclomiphene |
| Manufacturer | Dragon Pharma |
| Substance | Enclomiphene (trans-Clomiphene) |
| Strength | 25 mg per tablet |
| Packaging | 100 tablets in sealed sachet |
| Lab Test Result | 25.19 mg/tablet (tested 2025-10-16) |
| Half-Life | Approximately 10 hours |
| Recommended Cycle | 4-8 weeks (PCT or testosterone optimization) |
| Form | Oral tablet |
| Aromatization | No (SERM with anti-estrogen properties) |
| Dosage (Men) | 12.5-25 mg daily (protocol dependent) |
Dragon Pharma Enclomiphene is used for Post Cycle Therapy (PCT) to restore natural testosterone production after anabolic steroid cycles, as well as for testosterone optimization in non-cycle contexts. The following protocols represent evidence-based approaches for bodybuilders and athletes. Individual response may vary based on cycle compounds, duration, and personal biochemistry.
For comprehensive hormonal recovery, Enclomiphene can be stacked with other PCT agents. Consider combining with Nolvadex (Tamoxifen) at 10-20 mg daily for enhanced estrogen receptor blockade, particularly if gyno symptoms were present during cycle. For initial HPTA stimulation, some protocols incorporate HCG during the first 1-2 weeks of PCT (though not concurrently with Enclomiphene). Natural androgen supporters like Proviron at 25-50 mg daily can provide additional androgenic support during the transition period.
While Enclomiphene is not hepatotoxic, comprehensive PCT should include liver support if oral steroids were used in the preceding cycle. Include NAC (N-Acetyl Cysteine) at 600-1200 mg daily and a quality liver complex. For mood and neurotransmitter support during hormonal transition, consider adding magnesium glycinate and vitamin B6. Adequate zinc supplementation (30-50 mg daily) is crucial for testosterone synthesis support during PCT with Enclomiphene.
Latest independent laboratory analysis confirms Dragon Pharma Enclomiphene tablets contain 25.19 mg of Enclomiphene per tablet, verifying 100.76% accuracy to the labeled 25 mg dosage. This precise testing ensures you receive exactly what's promised for your Post Cycle Therapy and testosterone optimization needs.
To maintain optimal potency and stability of your Dragon Pharma Enclomiphene tablets:
Important: Keep out of reach of children and pets. Do not transfer tablets to unlabeled containers. The Dragon Pharma sachet packaging provides ideal storage conditions when kept in a cool, dark, dry location away from humidity and temperature fluctuations.
Enclomiphene is not a direct muscle-building compound like anabolic steroids, but it supports muscle building indirectly through testosterone optimization. By increasing natural testosterone production, it creates a more anabolic hormonal environment that can enhance muscle protein synthesis, improve recovery, and support strength gains. During Post Cycle Therapy, Enclomiphene helps preserve muscle mass that would otherwise be lost due to suppressed testosterone levels. Some studies show Enclomiphene can increase testosterone by 20-50% in hypogonadal men, which can translate to better training performance and body composition over time when combined with proper nutrition and training.
Enclomiphene begins working within hours of administration, with effects on gonadotropin (LH and FSH) secretion typically starting within 24-48 hours. However, measurable increases in testosterone levels usually become apparent within 5-7 days of consistent dosing. Peak testosterone response generally occurs between weeks 2-4 of treatment. For Post Cycle Therapy, users typically notice improved energy, libido, and mood within the first 1-2 weeks, with full hormonal recovery taking 4-8 weeks depending on the severity of prior suppression. The 10-hour half-life supports once-daily dosing while maintaining consistent hormonal stimulation.
Enclomiphene is actually protective against gynecomastia (gyno) rather than causative. As a Selective Estrogen Receptor Modulator, it blocks estrogen receptors in breast tissue, preventing estrogen from stimulating glandular growth. This makes it an effective treatment for existing mild gyno and a preventative measure against estrogen-related breast tissue development. However, during PCT when testosterone levels are rebounding, there can be a temporary increase in aromatization as testosterone converts to estrogen. Some users may experience transient nipple sensitivity, but this typically resolves as hormonal balance is restored. Enclomiphene's anti-estrogenic properties make it one of the safer SERMs regarding gyno risk.
Enclomiphene is the trans-isomer of Clomiphene, while regular Clomid contains both enclomiphene (62%) and zuclomiphene (38%) isomers. The key differences are:
Enclomiphene is not typically used as a testosterone base during steroid cycles because exogenous testosterone and many anabolic compounds suppress the HPTA regardless of SERM use. During a cycle with compounds like Sustanon or Testosterone blends, the hypothalamus detects sufficient androgens and reduces GnRH production, making SERMs ineffective for maintaining natural testosterone. However, some advanced users employ Enclomiphene during specific protocols:
For traditional cycles, exogenous testosterone remains the standard base.
Multi-Ester Testosterone Blend (5 Esters)
April 5, 2026
I've switched exclusively to Enclomiphene for all my PCT needs. The 25mg tablets are perfect - easy to split for precise dosing. Compared to research chemical Enclomiphene, Dragon Pharma feels more consistent batch to batch. Recovery seems faster and I keep more strength through PCT. The third-party testing is a game-changer for trusting what you're taking.